Recent developments in the immunobiology of rheumatoid arthritis

被引:72
作者
Andersson, Anna K. [1 ]
Li, Ching [1 ]
Brennan, Fionula M. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England
关键词
D O I
10.1186/ar2370
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progress into the understanding of immunopathology in rheumatoid arthritis is reviewed in the present article with regard to pro-inflammatory cytokine production, cell activation and recruitment, and osteoclastogenesis. Studies highlight the potential importance of T helper 17 cells and regulatory T cells in driving and suppressing inflammation in rheumatoid arthritis, respectively, and highlight other potential T-cell therapeutic targets. The genetic associations of the HLA shared epitope alleles with antibodies to citrullinated peptides in rheumatoid arthritis patients indicate that T cells are providing help to B cells to produce autoantibodies, and there is increasing evidence that these autoantibodies are pathogenic in rheumatoid arthritis.
引用
收藏
页数:9
相关论文
共 119 条
  • [21] IL-10 and TGF-β induce alloreactive CD4+CD25- T cells to acquire regulatory cell function
    Chen, ZM
    O'Shaughnessy, MJ
    Gramaglia, I
    Panoskaltsis-Mortari, A
    Murphy, WJ
    Narula, S
    Roncarolo, MG
    Blazar, BR
    [J]. BLOOD, 2003, 101 (12) : 5076 - 5083
  • [22] Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial
    Choy, EHS
    Panayi, GS
    Emery, P
    Madden, S
    Breedveld, FC
    Kraan, MC
    Kalden, JR
    Rascu, A
    Brown, JCC
    Rapson, N
    Johnston, JM
    [J]. RHEUMATOLOGY, 2002, 41 (10) : 1142 - 1148
  • [23] Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients
    Choy, EHS
    Connolly, DJA
    Rapson, N
    Jeal, S
    Brown, JCC
    Kingsley, GH
    Panayi, GS
    Johnston, JM
    [J]. RHEUMATOLOGY, 2000, 39 (10) : 1139 - 1146
  • [24] CHRONIC EXPOSURE TO TUMOR-NECROSIS-FACTOR (TNF) IN-VITRO IMPAIRS THE ACTIVATION OF T-CELLS THROUGH THE T-CELL RECEPTOR CD3 COMPLEX - REVERSAL IN-VIVO BY ANTI-TNF ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    COPE, AP
    LONDEI, M
    CHU, NR
    COHEN, SBA
    ELLIOTT, MJ
    BRENNAN, FM
    MAINI, RN
    FELDMANN, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 749 - 760
  • [25] Evaluating candidate autoantigens in rheumatoid arthritis
    Cope, AP
    Sonderstrup, G
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2): : 23 - 39
  • [26] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    Edwards, JCW
    Szczepanski, L
    Szechinski, J
    Filipowicz-Sosnowska, A
    Emery, P
    Close, DR
    Stevens, RM
    Shaw, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) : 2572 - 2581
  • [27] Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
    Ehrenstein, MR
    Evans, JG
    Singh, A
    Moore, S
    Warnes, G
    Isenberg, DA
    Mauri, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) : 277 - 285
  • [28] EMERY P, 1985, J RHEUMATOL, V12, P859
  • [29] Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis
    Fasth, Andreas Er
    Snir, Omri
    Johansson, Anna At
    Nordmark, Birgitta
    Rahbar, Afsar
    af Klint, Erik
    Bjorkstrom, Niklas K.
    Ulfgren, Ann-Kristin
    van Vollenhoven, Ronald F.
    Malmstrom, Vivianne
    Trollmo, Christina
    [J]. ARTHRITIS RESEARCH & THERAPY, 2007, 9 (05)
  • [30] APOPTOSIS IN RHEUMATOID-ARTHRITIS SYNOVIUM
    FIRESTEIN, GS
    YEO, M
    ZVAIFLER, NJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) : 1631 - 1638